Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we will assume that you are happy to receive all cookies and you will not see this message again. Click 'Find out more' for information on how to change your cookie settings.

A critical feature of obesity is enhanced insulin secretion from pancreatic β-cells, enabling the majority of individuals to maintain glycaemic control despite adiposity and insulin resistance. Surprisingly, the factors coordinating this adaptive β-cell response with adiposity have not been delineated. Here we show that fatty acid binding protein 4 (FABP4/aP2) is an adipokine released from adipocytes under obesogenic conditions, such as hypoxia, to augment insulin secretion. The insulinotropic action of FABP4 was identified using an in vitro system that recapitulates adipocyte to β-cell endocrine signalling, with glucose-stimulated insulin secretion (GSIS) as a functional readout, coupled with quantitative proteomics. Exogenous FABP4 potentiated GSIS in vitro and in vivo, and circulating FABP4 levels correlated with GSIS in humans. Insulin inhibited FABP4 release from adipocytes in vitro, in mice and in humans, consistent with feedback regulation. These data suggest that FABP4 and insulin form an endocrine loop coordinating the β-cell response to obesity.

Original publication

DOI

10.1016/j.molmet.2014.02.005

Type

Journal article

Journal

Mol Metab

Publication Date

07/2014

Volume

3

Pages

465 - 473

Keywords

Adipocyte, Adipokine, BMI, body mass index, Beta-cell, ELISA, enzyme-linked immunosorbant assay, FABP4, GSIS, glucose-stimulated insulin secretion, IBMX, 3-Isobutyl-1-methylxanthine, Insulin secretion, NEFA, non-esterified fatty acid, Obesity, SILAC, stable-isotope labelling by amino acids in cell culture, T2D, type 2 diabetes, cAMP, cyclic-AMP